Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome.

Lazova R, Camp RL, Klump V, Siddiqui SF, Amaravadi RK, Pawelek JM.

Clin Cancer Res. 2012 Jan 15;18(2):370-9. doi: 10.1158/1078-0432.CCR-11-1282. Epub 2011 Nov 11.

2.

High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.

Zhao H, Yang M, Zhao J, Wang J, Zhang Y, Zhang Q.

Med Oncol. 2013 Mar;30(1):475. doi: 10.1007/s12032-013-0475-1. Epub 2013 Feb 1.

PMID:
23371253
3.

Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer.

Choi J, Jung W, Koo JS.

Histopathology. 2013 Jan;62(2):275-86. doi: 10.1111/his.12002. Epub 2012 Nov 8.

PMID:
23134379
4.

Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.

Wu DH, Jia CC, Chen J, Lin ZX, Ruan DY, Li X, Lin Q, Min-Dong, Ma XK, Wan XB, Cheng N, Chen ZH, Xing YF, Wu XY, Wen JY.

Tumour Biol. 2014 Dec;35(12):12225-33. doi: 10.1007/s13277-014-2531-7. Epub 2014 Sep 26.

PMID:
25256671
5.

The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.

Chen S, Jiang YZ, Huang L, Zhou RJ, Yu KD, Liu Y, Shao ZM.

Clin Cancer Res. 2013 Dec 15;19(24):6853-62. doi: 10.1158/1078-0432.CCR-13-1617. Epub 2013 Oct 18.

6.

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.

Ladstein RG, Bachmann IM, Straume O, Akslen LA.

BMC Cancer. 2010 Apr 14;10:140. doi: 10.1186/1471-2407-10-140.

7.

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.

Ladoire S, Penault-Llorca F, Senovilla L, Dalban C, Enot D, Locher C, Prada N, Poirier-Colame V, Chaba K, Arnould L, Ghiringhelli F, Fumoleau P, Spielmann M, Delaloge S, Poillot ML, Arveux P, Goubar A, Andre F, Zitvogel L, Kroemer G.

Autophagy. 2015;11(10):1878-90. doi: 10.1080/15548627.2015.1082022.

8.
9.

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.

Slipicevic A, Holm R, Emilsen E, Ree Rosnes AK, Welch DR, Mælandsmo GM, Flørenes VA.

BMC Cancer. 2012 Feb 22;12:73. doi: 10.1186/1471-2407-12-73.

10.

Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.

Nazarian RM, Prieto VG, Elder DE, Duncan LM.

J Cutan Pathol. 2010 Apr;37 Suppl 1:41-7. doi: 10.1111/j.1600-0560.2010.01505.x.

PMID:
20482674
11.

Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival.

Wu KN, Queenan M, Brody JR, Potoczek M, Sotgia F, Lisanti MP, Witkiewicz AK.

Cell Cycle. 2011 Dec 15;10(24):4250-5. doi: 10.4161/cc.10.24.18551. Epub 2011 Dec 15.

PMID:
22134245
12.

Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.

Lefort S, Joffre C, Kieffer Y, Givel AM, Bourachot B, Zago G, Bieche I, Dubois T, Meseure D, Vincent-Salomon A, Camonis J, Mechta-Grigoriou F.

Autophagy. 2014;10(12):2122-42. doi: 10.4161/15548627.2014.981788.

13.

Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma.

Cha YJ, Kim YH, Cho NH, Koo JS.

Int J Clin Exp Pathol. 2014 May 15;7(6):3389-98. eCollection 2014.

14.

The pro-apoptotic role of autophagy in breast cancer.

Suman S, Das TP, Reddy R, Nyakeriga AM, Luevano JE, Konwar D, Pahari P, Damodaran C.

Br J Cancer. 2014 Jul 15;111(2):309-17. doi: 10.1038/bjc.2014.203. Epub 2014 Jun 19.

15.
16.

MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.

Yang F, Zhou X, Miao X, Zhang T, Hang X, Tie R, Liu N, Tian F, Wang F, Yuan J.

Breast Cancer Res Treat. 2014 May;145(1):23-32. doi: 10.1007/s10549-014-2915-9. Epub 2014 Apr 1.

17.

Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.

Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, Monciatti I, Mannucci S, Biagioli M, Toscano M, Moretti D, Lio R, Massi D.

Hum Pathol. 2010 Apr;41(4):503-12. doi: 10.1016/j.humpath.2009.09.004. Epub 2009 Dec 11.

PMID:
20004946
18.

Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients.

Zhang K, Zhu T, Gao D, Zhang Y, Zhao Q, Liu S, Su T, Bernier M, Zhao R.

J Cancer Res Clin Oncol. 2014 Nov;140(11):1913-26. doi: 10.1007/s00432-014-1722-3. Epub 2014 Jun 8.

PMID:
24908328
19.
20.

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.

Alford SH, Toy K, Merajver SD, Kleer CG.

Breast Cancer Res Treat. 2012 Apr;132(2):429-37. doi: 10.1007/s10549-011-1591-2. Epub 2011 May 26.

Supplemental Content

Support Center